NEW YORK, NY--(Marketwire - September 23, 2009) -
| Highlighted Links |
Dr. Samadi TV Interviews |
Contact Dr. Samadi |
Many prostate cancer patients dread surgery because of the recovery period and potential side effects such as impotence and incontinence. However, the study, which compared 102 traditional prostatectomy patients with 104 laparoscopic patients, showed very little differences in their outcomes. The risk of complication was only slightly higher with laparoscopic patients, with just a low rate of swelling and blood in the urine.
The study however did not include the more modern robotic prostatectomy surgery option. Dr. David B. Samadi, Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center in New York City, who has successfully performed over 2,000 of these procedures, uses precision robotic technology to remove the prostate gland with less blood loss and increased accuracy. Because it is minimally invasive, robotic surgery can salvage the delicate nerves surrounding the gland and preserve sexual function and continence, shorten hospital stays and speed recovery.
The study confirmed that the outcome does not depend on the surgery, but
the experience and judgment of the surgeon, with which Dr. Samadi
wholeheartedly agrees. Samadi, one of only a handful of surgeons that is
trained in all three disciplines, thinks the combination of experience is
vital in the successful treatment of prostate cancer. "The robot can fail,
it can happen," says Samadi, "which is why the surgeon must be able to then
turn to his open or laparoscopic experience to get the job done." Samadi
also takes a comprehensive approach in deciding which prostate cancer treatment method is best for his patients. Says Samadi, "Each
patient is different, therefore their treatment must be individualized for
greater success."
Digg this
Bookmark with del.icio.us
Add to Newsvine
Technorati:
